Kirsten Raun

Malov, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

The story of amylin: from physiology to therapy.

The story of amylin: from physiology to therapy.

Journal: Nature metabolism

Published: July 16, 2025

Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide.

Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide.

Journal: Life sciences

Published: March 12, 2025

The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats.

The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats.

Journal: EBioMedicine

Published: March 06, 2025

A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans.

A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans.

Journal: Molecular metabolism

Published: February 10, 2025

Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.

Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.

Journal: EBioMedicine

Published: February 06, 2025

A single dorsal vagal complex circuit mediates the aversive and anorectic responses to GLP1R agonists.

A single dorsal vagal complex circuit mediates the aversive and anorectic responses to GLP1R agonists.

Journal: bioRxiv : the preprint server for biology

Published: February 03, 2025

A Cross-Species Atlas of the Dorsal Vagal Complex Reveals Neural Mediators of Cagrilintide's Effects on Energy Balance.

A Cross-Species Atlas of the Dorsal Vagal Complex Reveals Neural Mediators of Cagrilintide's Effects on Energy Balance.

Journal: bioRxiv : the preprint server for biology

Published: January 27, 2025

CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure.

CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure.

Journal: Nature metabolism

Published: December 13, 2024

Correction to "NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin".

Correction to "NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin".

Journal: Journal of medicinal chemistry

Published: December 12, 2024

A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance.

A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance.

Journal: Nature metabolism

Published: November 15, 2024

NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin.

NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin.

Journal: Journal of medicinal chemistry

Published: July 03, 2024

Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors.

Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors.

Journal: Nature communications

Published: June 28, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026